FIG 4.

Neutralizing susceptibility to the Omicron BA.2 variant for 18 individual MAbs or MAb combinations. Each plot shows the IC₅₀s of the wild-type control variant (on the left) connected by a line to the IC₅₀s of the Omicron BA.1 variant (on the right) performed in the same study. The cyan boxes encompass the interquartile range. IC₅₀s at or above 10,000 ng/mL or recorded as being above “>1,000 ng/mL” are plotted as 10,000 ng/mL. The distribution of fold reductions in susceptibility is shown beneath each plot. Two studies that used a Delta variant control are not included in the plots.